Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Alzheimer's Research & Therapy

Alzheimer's Research & Therapy

Alzheimer's Research & Therapy

Editor-in-Chief: T.E. Golde; P. Scheltens; D.R. Galasko

ISSN: 1758-9193 (electronic version)

Journal no. 13195

BioMed Central

Open access BioMed Central
Learn more about the metrics of this journal
  • Official journal of Alzheimer's Disease International (ADI)
  • Rapid peer review with average time to first decision within five weeks
  • The leading open access journal for translational research into dementia and other neurodegenerative diseases

Leading the open access field for translational research into dementia and neurodegenerative diseases, Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease.  Affiliated with  Alzheimer’s Disease International (ADI), we publish basic research, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal offers rapid peer review with an average time to first decision within 5 weeks and publishes reviews, viewpoints, commentaries, debates and reports, as well as research articles.

Related subjects » Family & Geriatric Medicine - Neurology - Neuroscience - Psychiatry

Impact Factor: 5.015 (2017) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, Google Scholar, CNKI, EBSCO Academic Search, EBSCO Biomedical Reference Collection, EBSCO Discovery Service, EBSCO STM Source, EBSCO TOC Premier, Expanded Academic, Gale Academic OneFile, Health Reference Center Academic, OCLC, ProQuest - Summon

Read This journal on BioMed Central

For authors and editors


  • Journal Citation Reports®
    2017 Impact Factor
  • 5.015
  • Aims and Scope

    Aims and Scope

    Close

    Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

    Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

  • Submit Online
  • English Language Editing

    English Language Editing

    Close

  • Writing Resources: Training for Authors